Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats

By Turnbull A.V.   Vale W.   Rivier C.  

European Journal of Pharmacology, Vol. 303, Iss. 3, 1996-05 ,pp. : 213-216

Elsevier

Access to resources Recommend Favorite

Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats

By Sekino Azusa   Ohata Hisayuki   Mano-Otagiri Asuka   Arai Keiko   Shibasaki Tamotsu  

Psychopharmacology, Vol. 176, Iss. 1, 2004-10 ,pp. : 30-38

Springer Publishing Company

Access to resources Recommend Favorite

Corticotropin-releasing factor 1 receptor antagonists: a patent review

By Williams John P  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1057-1068

Informa Healthcare

Access to resources Recommend Favorite

Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances

By Wood Susan K   Woods James H  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1401-1413

Informa Healthcare

Access to resources Recommend Favorite

Corticotropin-releasing factor induces phosphorylation of phospholipase C- at tyrosine residues via its receptor 2 in human epidermoid A-431 cells

By Kiang J.G.   Ding X.Z.   Gist I.D.   Jones R.R.   Tsokos G.C.  

European Journal of Pharmacology, Vol. 363, Iss. 2, 1998-12 ,pp. : 203-210

Elsevier

Access to resources Recommend Favorite